Postmarket Surveillance Needed For Mallinckrodt OxiSure, FDA Panel Says

Mallinckrodt should conduct postmarket surveillance of caesarean-section rates at sites using the firm's OxiSure fetal oxygen saturation monitor as a condition of FDA approval, the agency's Obstetrics and Gynecology Devices Panel concluded Jan. 24.